- Login
- Register & Subscribe
- Language: EN FR DE
Regulation & Policy
BioCity Nottingham collaborates with three US science parks
Thursday 19 November 2009
BioCity Nottingham, a bioscience incubator in Britain’s East Midlands, has entered into collaboration agreements with three US regional science parks to promote better transatlantic opportunities for small biotech businesses.
Location
United Kingdom
See map: Google Maps
EMEA receives 24th report of PML case linked with Tysabri
Monday 26 October 2009
There has been a recent surge in new confirmed cases of progressive multifocal leukoencephalopathy (PML) associated with the multiple sclerosis drug, Tysabri (natalizumab), with the 24th case reported to the EMEA on 25 October.
Location
United Kingdom
See map: Google Maps
EMEA recommends approvals for two medicines
Monday 26 October 2009
The European Medicines Agency is recommending that two new medicines, one of which is a radiopharmaceutical, be granted marketing authorisations. It has also given the go-ahead for new indications for four currently licensed treatments.
Location
United Kingdom
See map: Google Maps
EMEA conducts review of Tysabri
Sunday 25 October 2009
The European Medicines Agency has announced a review of the multiple sclerosis drug, Tysabri (natalizumab), in light of reports of 23 cases where patients taking the drug have developed a rare brain infection known as progressive multifocal leukoencaphalopathy (PML).
Location
United Kingdom
See map: Google Maps
Four new drugs get positive EMEA opinions
Monday 28 September 2009
The European Medicines Agency is recommending that four new drugs be allowed onto the market in Europe including a new therapy from Sanofi-Aventis for the treatment of atrial fibrillation.
Location
United Kingdom
See map: Google Maps
Novartis and GSK vaccines for swine flu get go ahead from EMEA
Friday 25 September 2009
The European Medicines Agency has recommended that two vaccines for influenza A (H1N1), known as swine flu, be granted a European Union-wide marketing authorisation. The vaccines are Focetria from Novartis and Pandemrix from GlaxoSmithKline.
Location
United Kingdom
See map: Google Maps
Brussels seeks proposals for €156.3 million of research projects
Tuesday 22 September 2009
The European Commission’s research partnership with industry aimed at finding new ways of making drug development more efficient is preparing to launch a new series of projects valued at €156.3 million
Location
Belgium
EMEA’s Lönngren warns of differences in drug advice
Thursday 10 September 2009
Regulators who strive to ensure the safety of medicines sometimes give different advice to companies developing drugs than do health technology assessment (HTA) bodies that rule on the cost effectiveness of the same drugs.
Location
United Kingdom
See map: Google Maps
Geron submits further data while the FDA puts embryonic stem cell trial on hold
Tuesday 25 August 2009
Geron Corporation of Menlo Park, California, has submitted further animal data to the US Food and Drug Administration on its first-in-man study of a stem cell treatment for spinal cord injury and the agency has put a clinical hold on the study.
Location
United States
See map: Google Maps
Applications for new medicines rise at the EMEA
Tuesday 25 August 2009
The European Medicines Agency gave a record number of positive opinions for new medicines in 2008. However the number of applications that were rejected by the agency, or withdrawn by the applicant, also increased significantly, according to the EMEA’s 2008 annual report.
Location
United Kingdom
See map: Google Maps
Select a News Category
Recent Appointments
Tim Edwards elected chairman of BIA
Tuesday September 7 2010
Index Ventures appoints antibody expert as partner
Friday September 3 2010
Colin Stewart appointed CEO at Amarin
Friday August 20 2010
Karl Keegan nominated as CFO of Pharming
Friday August 20 2010
Axel Müller becomes CEO at SkyePharma
Thursday August 19 2010